PF-04895162
CAS No.
PF-04895162 ( ICA-105665;PF 04895162;ICA105665;PF 4895162 )
Catalog No. M16958 CAS No.
PF-04895162 (ICA-105665, PF 4895162) is an orally available agonist of neuronal Kv7 potassium channel, opens Kv7.2/7.3 and Kv7.3/7.5 potassium channels.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePF-04895162
-
NoteResearch use only, not for human use.
-
Brief DescriptionPF-04895162 (ICA-105665, PF 4895162) is an orally available agonist of neuronal Kv7 potassium channel, opens Kv7.2/7.3 and Kv7.3/7.5 potassium channels.
-
DescriptionPF-04895162 (ICA-105665, PF 4895162) is an orally available agonist of neuronal Kv7 potassium channel, opens Kv7.2/7.3 and Kv7.3/7.5 potassium channels, also known as KCNQ2/3 and KCNQ3/5 channels; ICA-105665 has demonstrated broad spectrum antiseizure activity in multiple animal models including maximal electroshock, 6 Hz seizures, pentylenetetrazole, and electrical kindling at doses from <1 to 5 mg/kg.Epilepsy Phase 1 Discontinued
-
SynonymsICA-105665;PF 04895162;ICA105665;PF 4895162
-
PathwayCell Cycle/DNA Damage
-
TargetPotassium Channel
-
RecptorPotassium Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number--
-
Formula Weight355.35
-
Molecular FormulaC19H15F2N3O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameN-(2-cyclopropyl-7-fluoro-4-oxoquinazolin-3(4H)-yl)-2-(4-fluorophenyl)ethanamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kasteleijn-Nolst Trenité DG, et al. Epilepsia. 2013 Aug;54(8):1437-43.
2. Aleo MD, et al. Pharmacol Res Perspect. 2019 Feb;7(1):e00467.
3. Bialer M, et al. Epilepsy Res. 2013 Jan;103(1):2-30.
4. Roeloffs R, et al. J Pharmacol Exp Ther. 2008 Sep;326(3):818-28.
2. Aleo MD, et al. Pharmacol Res Perspect. 2019 Feb;7(1):e00467.
3. Bialer M, et al. Epilepsy Res. 2013 Jan;103(1):2-30.
4. Roeloffs R, et al. J Pharmacol Exp Ther. 2008 Sep;326(3):818-28.
molnova catalog
related products
-
ASP 2905
A novel potent, selective, orally bioavailable inhibitor of voltage-gated potassium channel KCNH3 with IC50 of 9.0 nM.
-
Gut restricted-7
Gut restricted-7 (GR-7) is a covalent and orally active pan-bile salt hydrolase (BSH) inhibitor. It decreases gut bacterial BSHs and decreases deconjugated bile acid levels in the feces of mice.
-
Dronedarone hydrochl...
A multichannel blocker agent that has antiarrhythmic activity.